Digital Health in Diabetes and Cardiovascular Disease

被引:4
作者
Avoke, Dorothy [1 ]
Elshafeey, Abdallah [1 ]
Weinstein, Robert [2 ]
Kim, Chang H. [3 ]
Martin, Seth S. [1 ,2 ,3 ,4 ]
机构
[1] Johns Hopkins Univ Hosp, Dept Med, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA
[3] Johns Hopkins Univ, Div Cardiol, Sch Med, Baltimore, MD USA
[4] Johns Hopkins Univ Hosp, Johns Hopkins Sch Med, Dept Med, Ciccarone Adv Lipid Disorders Clin, 600 N Wolfe St,Carnegie 591, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
Cardiovascular disease; diabetes mellitus; digital health technology; lifestyle management; mobile health; wearable devices; BLOOD-PRESSURE; ARTIFICIAL-INTELLIGENCE; RISK-FACTORS; CARE; OBESITY; MANAGEMENT; GLUCOSE; SYSTEM; HYPERGLYCEMIA; EPIDEMIOLOGY;
D O I
10.1080/07435800.2024.2341146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundDigital health technologies are rapidly evolving and transforming the care of diabetes and cardiovascular disease (CVD).Purpose of the reviewIn this review, we discuss emerging approaches incorporating digital health technologies to improve patient outcomes through a more continuous, accessible, proactive, and patient-centered approach. We discuss various mechanisms of potential benefit ranging from early detection to enhanced physiologic monitoring over time to helping shape important management decisions and engaging patients in their care. Furthermore, we discuss the potential for better individualization of management, which is particularly important in diseases with heterogeneous and complex manifestations, such as diabetes and cardiovascular disease. This narrative review explores ways to leverage digital health technology to better extend the reach of clinicians beyond the physical hospital and clinic spaces to address disparities in the diagnosis, treatment, and prevention of diabetes and cardiovascular disease.ConclusionWe are at the early stages of the shift to digital medicine, which holds substantial promise not only to improve patient outcomes but also to lower the costs of care. The review concludes by recognizing the challenges and limitations that need to be addressed for optimal implementation and impact. We present recommendations on how to navigate these challenges as well as goals and opportunities in utilizing digital health technology in the management of diabetes and prevention of adverse cardiovascular outcomes.
引用
收藏
页码:124 / 136
页数:13
相关论文
共 113 条
[1]  
Activity Monitors, 2023, WWW OMRON HEALTHCARE
[2]   Applications of artificial intelligence-assisted retinal imaging in systemic diseases: A literature review [J].
Al-Halafi, Ali M. .
SAUDI JOURNAL OF OPHTHALMOLOGY, 2023, 37 (03) :185-192
[3]   Revolutionizing healthcare: the role of artificial intelligence in clinical practice [J].
Alowais, Shuroug A. ;
Alghamdi, Sahar S. ;
Alsuhebany, Nada ;
Alqahtani, Tariq ;
Alshaya, Abdulrahman I. ;
Almohareb, Sumaya N. ;
Aldairem, Atheer ;
Alrashed, Mohammed ;
Bin Saleh, Khalid ;
Badreldin, Hisham A. ;
Al Yami, Majed S. ;
Al Harbi, Shmeylan ;
Albekairy, Abdulkareem M. .
BMC MEDICAL EDUCATION, 2023, 23 (01)
[6]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc12-s011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc14-S081, 10.2337/dc11-S062, 10.2337/dc12-s064, 10.2337/dc11-S011, 10.2337/dc10-S011, 10.2337/dc10-S062]
[7]  
Anderson John E, 2020, Diabetes Spectr, V33, P165, DOI 10.2337/ds19-0031
[8]  
[Anonymous], Remote patient monitoring: Cardiocom | telehealth services telemonitoring
[9]  
[Anonymous], Artificial Intelligence and Intellectual Property: Copyright and Patents'
[10]  
[Anonymous], 2019, GLUCOSE BUDDY